Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-: European
Although friability is sometimes considered a "secondary" test, Monograph 0478 references it explicitly for uncoated tablets.
Apparatus: Roche Friabilator (drum rotating at 25 RPM). Procedure: Dedust 10 tablets. Weigh exactly. Rotate for 100 revolutions (4 minutes). Dedust and reweigh. Acceptance criteria:
Exception: Effervescent tablets and chewable tablets are exempt from friability testing due to their intended use.
One of the most critical sections of 0478 deals with Uniformity of Dosage Units. In a manufacturing run of millions of pills, how do you ensure every single one has the exact same amount of medicine?
The monograph references strict testing methods to ensure that the variance between tablets is statistically insignificant. This is where the "mass variation" test meets the "content uniformity" test. If a tablet contains a tiny amount of potent API (like a hormone or an opioid), weighing the tablet isn't enough; chemists must assay the content of individual units. 0478 dictates when to use which method, ensuring that a patient never receives a "super-potent" or "sub-potent" dose.
The European Pharmacopoeia (Ph. Eur.) Monograph 0478 is the foundational quality standard for tablets intended for oral administration in Europe. Published by the European Directorate for the Quality of Medicines & HealthCare (EDQM), it establishes legally binding requirements for the definition, production, and testing of diverse tablet forms to ensure patient safety and therapeutic efficacy. 1. Scope and Definition
According to the monograph, tablets are solid preparations, each containing a single dose of one or more active substances. They are primarily obtained by compressing uniform volumes of particles but can also be manufactured via extrusion, moulding, or freeze-drying (lyophilisation).
The monograph explicitly excludes preparations like lozenges, oral pastes, and oral gums , which are covered under separate general chapters such as Oromucosal Preparations (1807). 2. Recognized Categories of Tablets European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-
Monograph 0478 distinguishes several specific categories, each with tailored requirements:
Uncoated Tablets: Single or multi-layer tablets without specific release-modifying excipients.
Coated Tablets: Finished with layers of resins, sugars, or polymers (film-coated) to protect the core or mask taste.
Modified-Release: Includes prolonged-release and pulsatile-release tablets designed to alter the rate or timing of drug delivery.
Gastro-Resistant: Delayed-release tablets intended to resist gastric fluid and release the active substance in the intestinal tract.
Effervescent: Formulated with carbonates to react in water and release carbon dioxide for rapid dispersion.
Orodispersible and Soluble: Tablets designed to disperse rapidly in the mouth or dissolve in water before administration. 3. Production and Quality Control Requirements One of the most critical sections of 0478
Manufacturers must implement measures to ensure tablets possess sufficient mechanical strength to withstand handling. Standardized testing includes:
Resistance to Crushing: Measured in Newtons, typically on a sample of 10 tablets to determine the force required for disruption.
Friability: Assessed via general chapter 2.9.7 to ensure tablets do not crumble or break during processing or transport.
Subdivision (Scoring): For tablets with break-marks, the efficacy of the mark is assessed by weighing subdivided parts. Not more than one out of 30 parts may fall outside 85% to 115% of the average mass. 4. Mandatory Pharmacopoeial Tests
Compliance with Monograph 0478 requires several critical laboratory tests, often cross-referencing general chapters:
Disintegration (2.9.1): Uncoated tablets must typically disintegrate within 15 minutes in water at 37°C. Coated tablets (non-film) are allowed up to 60 minutes.
Dissolution (2.9.3): Since January 2018, revised standards mandate a suitable dissolution test for immediate-release forms unless otherwise justified. it must survive manufacturing
Uniformity of Dosage Units (2.9.40): Ensures each tablet in a batch contains the correct amount of active pharmaceutical ingredient (API). Summary of Standard Disintegration Times Tablet Type Max Time Allowed 15 minutes Film-coated 30 minutes Other Coated 60 minutes Soluble/Dispersible Water (15–25°C) Effervescent Water (15–25°C) Revised Ph. Eur. Chapter Tablets - gmp-compliance.org
The European Pharmacopoeia (Ph. Eur.) Monograph 0478 (Tablets/Compressi) serves as the legally binding foundational standard for all tablet dosage forms in Europe. It ensures that regardless of the manufacturer, tablets meet consistent quality, safety, and efficacy requirements through rigorous manufacturing and testing protocols. Scope and Definitions
Monograph 0478 defines tablets as solid preparations containing a single dose of one or more active substances. They are primarily produced by compressing particles but can also be made through extrusion or freeze-drying (oral lyophilisates). This general monograph covers various categories, including: Uncoated and Coated Tablets. Gastro-resistant and Modified-release Tablets. Effervescent, Soluble, and Dispersible Tablets.
Orodispersible Tablets (disintegrating in the mouth within 3 minutes). Key Quality Control Requirements
The monograph outlines several mandatory tests that assess both physical integrity and chemical uniformity: European Pharmacopoeia - Background and Mission
Tablets are solid preparations each containing a single dose of one or more active substances. They are obtained by compressing uniform volumes of particles or by another suitable manufacturing process (e.g., compaction, granulation followed by compression).
Before a tablet ever reaches a patient, it must survive manufacturing, bottling, shipping, and handling. This is where the physical attributes described in 0478 come into play.
The monograph demands that tablets be "sufficiently hard to withstand handling." But it also introduces the concept of friability (often referenced in conjunction with the monograph). Friability is the tendency of a tablet to crumble. If a tablet is too hard, it won't dissolve; if it's too soft, it turns to dust in the bottle. Monograph 0478 ensures that the definition of "quality" includes structural integrity, preventing patients from receiving a partial dose due to chipped or broken pills.